In Vitro Activity of a Novel Siderophore-Cephalosporin LCB10-0200 (GT-1), and LCB10-0200/Avibactam, against Carbapenem-Resistant Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa Strains at a Tertiary Hospital in Korea

The siderophore–antibiotic conjugate LCB10-0200 (a.k.a. GT-1) has been developed to combat multidrug-resistant Gram-negative bacteria. In this study, the in vitro activity of LCB10-0200 and LCB10-0200/avibactam (AVI) has been investigated against carbapenem-resistant Escherichia coli, Klebsiella pne...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Le Phuong, Park, Chul Soon, Pinto, Naina Adren, Lee, Hyunsook, Seo, Hyun Soo, Vu, Thao Nguyen, Mai, Hung, Pham, An H. T., Jang, Eris, Cho, Young Lag, Goglin, Karrie, Nguyen, Kevin, White, Richard, D’Souza, Roshan, Fouts, Derrick E., Yong, Dongeun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072773/
https://www.ncbi.nlm.nih.gov/pubmed/33923801
http://dx.doi.org/10.3390/ph14040370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072773/
https://www.ncbi.nlm.nih.gov/pubmed/33923801
http://dx.doi.org/10.3390/ph14040370

Ejemplares similares